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Summary 
Background 
Intraoperative monitoring of neuronal functions is important in a variety of surgeries. The type of 
general anaesthetic used may have an important influence on the interpretation and quality of the 
obtained recordings. Although primary effects of general anaesthetics are synaptic-mediated, it 
remains unclear to what extent they affect excitability of the peripheral nervous afferent system. 
Methods 
40 patients were randomised in a stratified manner into two equally sized groups. Induction was 
performed either with propofol or sevoflurane. We used the technique of threshold tracking (QTRAC®) 
to measure nerve excitability parameters of the sensory action potential of the median nerve before 
and after induction of general anaesthesia.  
 
Results 
Only a small number of parameters of peripheral nerve excitability of sensory afferents changed after 
induction of general anaesthesia and they were similar for both, propofol and sevoflurane. The 
maximum amplitude of the sensory nerve action potential decreased in both groups significantly 
(Propofol: 25.3 %; Sevoflurane: 29.5 %; both P < 0.01). The relative refractory period also decreased 
similarly in both groups (Propofol: -0.6 (0.7) ms; Sevoflurane: -0.3 (0.5) ms; both P < 0.01). Skin 
temperature at the stimulation site increased significantly in both groups (Propofol: +1.2 (1.0) °C; 
Sevoflurane: +1.7 (1.4) °C; both P < 0.01).  
 
Conclusions 
Changes of excitability of primary sensory afferents after induction of anaesthesia with propofol and 
sevoflurane were subtle and have been found under high concentrations of the anaesthetics. They 
were non-specific and can potentially be explained by the temperature changes found. 
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Intraoperative monitoring of neuronal function is important in a variety of surgeries. It is well known 
that the type and concentration of general anaesthetics have an important influence on the quality of 
the neurophysiological signals recorded and, hence their interpretation.1 All the electrophysiological 
(clinical) investigations have so far considered the effect of general anaesthetics on afferent axons as 
negligible, since axons are not usually considered as neural targets for these agents.2-4 In the 
peripheral nervous system, a well organized interaction of different subtypes of voltage-gated ion 
channels defines the size, frequency and the speed of an action potential. Even a slight shift in 
membrane potential of a nerve membrane can lead to severely altered excitability properties, and 
thereby modulate the information conveyed to the central nervous system.5 6 Propofol and 
sevoflurane seem to affect human voltage-gated ion channels at clinically relevant concentrations and 
therefore could contribute to the effects on peripheral afferent excitability. 7-10 
The aims of our investigation were to test whether propofol and sevoflurane have different effects on  
axonal excitability of peripheral sensory afferents after induction of general anaesthesia and how 
sensory nerve monitoring could be influenced during anaesthesia. 
We used the technique of threshold tracking, a diagnostic tool which assesses axonal nerve 
excitability of myelinated peripheral nerves in a non-invasive manner.11-13 In contrast to conventional 
nerve conduction studies threshold tracking technique uses subthreshold currents and provides 
information about nerve excitability and ion channel function. 
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Methods 
Study subjects and randomisation 
Study subjects: The study was performed at the University Hospital Zurich after approval by the local 
ethics committee (University Hospital Zurich, StV. 5-2008) and in accordance with the Declaration of 
Helsinki 2008 (registration number NCT00696254, www.clinicaltrials.gov). All study subjects gave 
written informed consent after careful instructions concerning the study details, in particular they 
agreed on the omission of premedication with a tranquiliser to exclude as many unknown influencing 
factors as possible. Inclusion criteria were: German speaking patients scheduled for surgery under 
general anaesthesia; age 18 – 70 years; weight 50 - 100 kg; signed informed consent. Exclusion 
criteria were: Known peripheral neuropathy; diabetes mellitus; neuro-psychiatric diagnosis; pregnant/ 
breast-feeding women; congestive heart disease; more than 2 risk factors out of 4 for postoperative 
nausea and vomiting (PONV): female, non-smoker, known PONV, planned opioids postoperatively; 
participation in other studies; inability of verbal expression. 40 patients were randomised in a stratified 
manner into two equally sized groups of 20 subjects (Figure 1). Induction was performed either with 
propofol or sevoflurane. 
 
Threshold tracking 
We used a computer-assisted threshold tracking program (QTRAC © Institute of Neurology, Queen 
Square, London, UK) to investigate the excitability parameters of myelinated axons and ion 
conductances in the median nerve.11-14 This technique provides different information than 
conventional nerve conduction studies which use supramaximal stimuli and provide information about 
conduction velocity and amplitude. Threshold tracking technique uses subthreshold currents and 
provides information about excitability and ion channel function. For more details about the technique 
itself and the electric model which it is the base for the understanding and correct interpretation of the 
data obtained refer to previous publications.11 13-16 
In the current study we measured the excitability of the median nerve stimulated transcutaneously at 
the wrist (Figure suppl. A-C). The sensory nerve action potential (SNAP) was recorded antidromically 
at Dig. II with skin electrodes. The temperature at the stimulation site was measured at the end of 
each measurement. We used a recording protocol comprising 5 main parts: Stimulus-response curve, 
strength-duration relationship, recovery cycle, threshold electrotonus and current-threshold 
relationship. Further information about the stimulation patterns in our protocols, how the 
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measurements were plotted and interpreted, is provided in the supplemental method and suppl. 
figure.  
 
Excitability measurements during anaesthesia induction in patients 
The study was performed in the anaesthesia induction room in the hospital’s OR facility. After the 
completion of the first nerve excitability measurement immediately prior to induction, the anaesthesia 
was administered exclusively with propofol or sevoflurane, respectively. Notably, no local 
anaesthetics, muscle relaxants or opioids were used until the second measurement was completed. 
Pulse oxymetry (Draeger Infinity Delta Systems, Draeger Medical Systems, Danvers, MA) was 
attached on a finger on the same arm where we measured the nerve excitability. Subjects were 
monitored with ECG, non-invasive blood pressure (NIBP) and and end-tidal gas analysis (FiO2 and 
etCO2; volume %) using a KION anaesthesia workstation (KION workstation and Maquet SC 7000 
screen, Maquet-Siemens, Rastatt, Germany). During the first measurement, baseline end-tidal CO2 
values were determined during quiet spontaneous respiration using a tight face mask. In order to 
reach a comparable depth of anaesthesia in both groups we aimed at a stable BIS value below 40 
(BIS QuatroTM sensors with Infinity® BISx Pod for Draeger; Software version 1.03, Aspect Medical 
Systems, Inc., Norwood, MA). According to this parameter we varied the target concentration of the 
propofol infusion (using a software-controlled infusion pump with the pharmacological model of 
Schnider et al. 17 programmed to plasma concentration) and the inspiratory concentration of 
sevoflurane, respectively. To minimize burning pain at the i.v. cannulation site the intravenous 
lactated Ringer’s infusion was infused at a high flow rate until the patient was deeply sedated. For the 
induction of anaesthesia with sevoflurane we asked the subjects to breath 100 % oxygen for 3 
minutes with a tightly sealed oxygen mask. To begin anaesthesia, we opened the sevoflurane 
vaporizer maximally (8 %) and then decreased the concentration gradually over the next few minutes. 
Controlled manual ventilation was used to stabilise ventilation, maintaining end-tidal CO2 values at 
the baseline level 
Before we recorded the second measurement we adjusted the concentrations of anaesthetics until 
the patients were in a steady state which was defined as follows: end-tidal CO2 persistently at 
baseline level, haemodynamic stability, BIS consistently < 40, constant calculated plasma 
concentration of propofol or difference of inspired and expired concentration of sevoflurane < 0.3 %, 
respectively. 
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The second nerve excitability measurement was performed when a sustained steady state was 
established (end-tidal CO2 persistently at baseline level, haemodynamic stability, BIS consistently < 
40, difference of inspired and expired concentration of sevoflurane < 0.3 %). After the second 
measurement was recorded, the study ended for the patient.  Standard anaesthesia techniques were 
carried out by addition of a muscle relaxant, opioid and benzodiazepine where indicated. The 
anaesthesia was continued according to institutional standards for the respective procedures. 
 
Statistical Analysis 
All values are given as means and standard deviations (SD) except in figures 3, 4 and Suppl. Figures 
2 and 3 where standard errors of the mean (SEM) were used to visualise the significance between 
groups. To analyse data we used the software QtracP (Version 3/4/2009, ® Institute of Neurology, 
University College London, UK). Data were tested for a normal distribution with Lilliefors test for 
normality. Gender was compared between groups using Fisher’s exact test. Data before and after 
induction of anaesthesia within the same group were analysed with a paired t-test. To compare 
excitability changes between the two groups after induction of anaesthesia we used an unpaired t-
test. A Bonferroni correction was performed to address multiple comparisons for the same variable. 
Thus, p-values of comparisons before and after induction of anaesthesia within the same group and 
between groups after intervention were considered significant if p < 0.013. 
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Results 
Changes of general parameters during anaesthesia induction 
We enrolled 17 female and 23 male patients in the investigation (Fig. 1). All 40 patients completed the 
study. The demographic data of the studied population before starting anaesthesia are shown in table 
1. After inducing anaesthesia, a comparable anaesthesia depth was achieved during the second 
measurement in both groups (Propofol: BIS 25 (8). Sevoflurane: 27 (10); P = 0.42). The calculated 
plasma concentration of propofol during the second measurement was 6.6 (1.3) µg ml-1. The end-
expiratory sevoflurane concentration was 5.5 (1.3) %. The concentration of end-expiratory CO2 during 
and after the induction of anaesthesia was not significantly higher than the value during spontaneous 
breathing before anaesthesia induction (Propofol spontaneous: 4.5 (0.5) kPa; anaesthetised: 4.6 (0.5) 
kPa, P = 0.09. Sevoflurane spontaneous: 4.6 (0.4) kPa; anaesthetised: 4.6 (0.4) kPa, P = 0.72.). 
There was no difference in the end-expiratory CO2 levels between the two groups before (P = 0.59) or 
after induction of anaesthesia (P = 0.84) (Fig. 2 A). Skin temperature at the stimulation site increased 
significantly in both groups, (Propofol before: 32.5 (0.9) °C; after: 33.7 (1.1) °C, P < 0.01. Sevoflurane 
before: 32.4 (1.2) °C; after: 34.1 (1.0) °C, P < 0.01). No difference existed between the groups after 
induction of anaesthesia (P = 0.17) (Fig. 2 C). Mean arterial pressure dropped significantly in both 
groups (Propofol before: 101 (13) mmHg; after: 81 (12) mmHg, P < 0.01. Sevoflurane before: 101 
(14) mmHg; after: 78 (12) mmHg, P < 0.01) but was similar when compared between the groups (P = 
0.55) after the induction (Fig. 2 D). Blood pressure stabilised after reaching equilibrium of anaesthetic 
depth, end-expiratory CO2 concentration, stable BIS value and stable SO2. We did not need to take 
any pharmacological or other measures in any of the patients to stabilise blood pressure. 
 
Changes of excitability parameters during anaesthesia induction 
A summary of the excitability changes during the anaesthesia induction is given in table 2 and table 3. 
We observed significant changes in only three excitability parameters following the induction of 
anaesthesia. 
First, the maximum amplitude of the SNAP decreased in both groups significantly (Before propofol: 
39.9 (5.8) µV; after: 29.8 (4.4) µV, P < 0.01. Before sevoflurane: 47.1 (7.8) µV; after: 33.2 (5.3) µV, P 
< 0.01) which corresponds to a decrease of 25.3 % and 29.5 %, respectively (Fig. 3). No difference 
was observed between the two groups after induction of anaesthesia (P = 0.44). As a result, the 
stimulus-response curve shifted downwards on the stimulus-response plot. In the group with 
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sevoflurane, additionally a distinctive shift of the curve to the right was observed. For this group, this 
implies that more current was needed to elicit the target action potential. 
Second, during the early phase of the recovery cycle, the curve shifted to the left in both groups (Fig. 
4).  Consequently, the first intersection with the control threshold (the current that is normally needed 
to elicit the targeted size of the action potential, plotted as a straight line at 0 % on the y-axis) and 
representing the end of the relative refractory period (RRP, s. Suppl. Fig. 5 C.), occurred earlier. The 
RRP decreased similarly in both groups (Before propofol: 4.4 (1.2) ms; after: 3.9 (1.1) ms, P = 0.01. 
Before sevoflurane: 4.0 (1.1) ms; after: 3.7 (1.2) ms, P < 0.01). No difference was observed between 
the two groups after induction of anaesthesia (P = 0.28). 
Third, the overshoot after a hyperpolarising conditioning stimulus was less prominent after 
anaesthesia induction (Before propofol: 20.3 (2.9) %; after: 16.1 (3.4) %, P = 0.01. Before 
sevoflurane: 19.7 (6.2) %; after: 14.5 (5.6) %, P = 0.01; Table 3). ‘Overshooting’ represents an 
increase in current required to reach the target threshold after the end of the hyperpolarising 
conditioning stimulus.15 It corresponds to the activities of certain voltage gated membrane ion 
channels (mainly slow potassium currents) which counteract the changes of the membrane potential 
induced by the hyperpolarising conditioning stimulus. Consequently, we would also expect a 
decrease of excitability at the end of the hyperpolarising stimulus (e.g. at TEh [90-100ms]). However, 
this parameter remained stable after induction, which cannot be conclusively explained at present. 
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Discussion 
This study shows for the first time that general anaesthesia affects excitability of primary sensory 
afferents significantly. Using subthreshold currents rather than supramaximal currents could detect 
smaller changes of nerve excitability properties than conventional nerve conduction studies or SSEP.  
 
Possible intrinsic effect of anaesthetics on excitability parameters 
Previous studies have shown that both anaesthetics alter nerve excitability at clinically relevant 
concentrations by modulating voltage-gated sodium and/or potassium channels in the central and 
peripheral nervous system.7 8 10 12 18 In our investigation, parameters sensitive to changes in 
membrane potential remained almost unchanged after the induction of anaesthesia. However, we 
found three parameters which could be explained by an intrinsic effect of the general anaesthetics on 
peripheral nerve excitability: 
(i) The relative refractory period was shorter: Investigations with the same threshold-tracking 
technique have shown that blocking of sodium channels results in a shift of the recovery 
cycle curve to the left combined with a decrease of superexcitability in sensory afferents. 
19
 
20
 The latter parameter, however, remained unchanged in our investigation. 
(ii)  The amplitude of the maximum peak response decreased: The size of a compound 
action potential decreases by temporal dispersion caused by different underlying 
mechanisms: differential slowing of individual fibers, availability of the largest-diameter 
fibers and changes in the amplitude of individual spikes.21 22 An intrinsic blocking of 
voltage-gated sodium channels could have led to a reduced size of peak response.23 
However, this conclusion could only be drawn in stable recording conditions. In our study, 
the temperature at the stimulation site changed significantly and, therefore, was likely to 
have an important influence on the response size (s. below). 
(iii) We observed no change in latency: According to previously published data we would 
expect a pronounced decrease in latency, hence increase in conduction velocity, of about 
3 % caused by the extent of temperature change at the stimulation site.24 But the 
latencies remained unchanged before and after the induction of anaesthesia. This could 
imply that the faster kinetics of the voltage-gated ion channels induced by the higher 
temperature (s. below) was counteracted by a partial block of sodium channels.  
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None of the above findings, however, are specific for an intrinsic effect of the investigated general 
anaesthetics on nerve excitability. Temperature change at the stimulation site increased significantly 
and, therefore, has to be taken into account when interpreting these results. 
 
Changes of excitability caused by an increase of skin temperature during anaesthesia induction. 
Temperature variation results in several changes of peripheral nerve excitability. Although in our 
study the temperature differences between the first and the second measurement were small, they 
were significant. We can explain this by a decrease in sympathetic activity.25 Consequently, a change 
in skin microcirculation occurred and resulted in a vasodilation with a substantial increase in skin 
temperature.26 27 Temperature changes affect all nerve excitability indices measured with threshold 
tracking to some extent.28 The most prominent effect is a decrease of the refractoriness with 
increasing temperature.24 28 Our results are in line with this finding, reflected by the leftward shift of 
the recovery cycle curve indicating a shortening of the relative refractory period. The underlying 
mechanism is a faster recovery from inactivation of voltage-gated sodium channels due to the higher 
temperature.29 
An increase in temperature also leads to a linear increase in conduction velocity.30 31 According to 
previously published data we would expect a decrease in latency of about 3 % caused by the extent 
of temperature change measured in our study.24 However, latencies were not different and also, we 
did not find a linear relationship of refractoriness and latency changes described by Burke et al.28 
Therefore we might assume that the temperature change of around 1.5 °C was too small to affect 
excitability. Also, temperature changes affect conditioned evoked potentials much more than 
unconditioned potentials.28 Refractoriness – in contrast to conduction velocity - was measured with a 
supramaximal conditioning stimulus, therefore, our findings would fit well with this theory. 
In our investigation the size of the compound action potential decreased after induction of 
anaesthesia with both anaesthetics. The effect of temperature on the size of the compound action 
potential is more complex to explain. On one hand, the compound action potential is sensitive to 
temporal dispersion of individual action potentials of nerve axons. Increasing the temperature, 
therefore, decreases the amount of dispersion of the compound action potential and results in greater 
amplitude.31 On the other hand, an increase of temperature decreases the duration of the action 
potential and leads to a smaller action potential. Hence, the measured size of the action potential at 
higher temperatures is a combination of both effects. In the study by Kiernan et al. who investigated 
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motor nerve fibres, the peak amplitude increased only when rising the temperature between 32° C to 
35° C, although the overall effect of temperature increase was a decrease of SNAP.24 Similar non-
linear functions between SNAP size and temperature changes have been described by Ludin et al.30  
 
Anaesthesia depth, ventilation and haemodynamic changes did not affect the measurements 
Our study endpoint was to compare the effect on peripheral nerve excitability of two different general 
anaesthetics at an equipotent dosage. Clinically, at first glance these concentrations appear to be 
high because propofol and sevoflurane are usually used in combination with co-anaesthetics (e.g. 
opioids or benzodiazepines). In our study however, patients were not premedicated and until the end 
of the second measurement we did not use any other co-medication. Consequently, the target 
plasma concentrations of propofol and the end-expiratory sevoflurane concentrations had to be 
chosen higher than normally to reach BIS values below  40. 
Several parameters which could have influenced nerve excitability were controlled very closely. In our 
study, anaesthesia induction was performed exclusively by one senior anaesthesiologist and 
normoventilation was achieved throughout the recording period. We cannot fully exclude alveolar 
hypercapnia. However, according to previously published data strength-duration time constant would 
probably be the most sensitive parameter to d tect hypercapnia.32 Since this parameter also 
remained unchanged we may assume that alveolar pCO2 did not influence our measurements. 
According to our measurements, depth of anaesthesia was equal in both groups and therefore 
contributed equally – if at all – to the measured excitability changes.  
Although induction of anaesthesia caused a significant drop in blood pressure values, they never 
reached low physiological values. Furthermore, the oxygen saturation in the same arm remained 
stable.  Therefore, we are sure that the perfusion pressure in the neuronal tissue at the stimulation 
site was high enough to prevent hypoperfusion or hypoxemia of the nerve and did not cause 
previously described changes in excitability.33-35 
 
Conclusion 
Induction of general anaesthesia with propofol and sevoflurane resulted in a change of excitability of 
primary sensory afferents. These changes were subtle and have been found under high 
concentrations of the anaesthetics. A direct effect of general anaesthetics on excitability could not be 
excluded and was minimal at most; it is more likely that the significant changes we found were 
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caused by an increase in temperature at the site of stimulation. Further investigations with specific 
designs are needed to elucidate the differentiation between the two mechanisms. However, our 
findings should raise the awareness of possible interference during intraoperative neuromonitoring 
caused by general anaesthetics in the peripheral nervous system.  
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Table 1. Demographic data. 
 PROPOFOL SEVOFLURANE P value 
Age (y) 43 (14) 39 (12) 0.37 
Weight (kg) 77 (10) 72 (15) 0.37 
Height (cm)                      177 (7) 173 (11) 0.30 
Female/male          6/14 11/9 0.21 
 
Values are presented as number (n) or as mean and (SD). P < 0.05 is considered statistically 
significant. 
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Table 2: Overview of measured parameters. 
 
  
before 
PROPOFOL 
after 
PROPOFOL P value 
before 
SEVOFLURANE 
after 
SEVOFLURANE P value P value* 
Latency (ms) 4.9 (0.5) 4.9 (0.4) 0.17 4.9 (0.4) 4.9 (0.4) 0.16 (0.85) 
Peak response 
SNAP (µV) 39.9 (5.8) 29.8 (4.4) <0.01 47.1 (7.8) 33.2 (5.3) <0.01 (0.44) 
Strength-duration 
time constant (µS) 
665 (135) 657 (134) 0.67 668 (184) 599 (265) 0.21 (0.40) 
Rheobase (mA) 7.1 (1.6) 6.7 (1.5) 0.30 6.6 (1.6) 6.4 (1.6) 0.82 (0.73) 
Relative refractory 
period (ms) 4.4 (1.2) 3.9 (1.1) <0.01 4.0 (1.1)  3.7 (1.2) <0.01 (0.28) 
Superexcitability 
(%) -14.1 (5.8) -15.1 (5.0) 0.30 -18.1 (10.2) -15.1 (7.5) 0.14 (0.93) 
Subexcitability (%) 13.6 (6.5) 12.0 (4.0) 0.17 12.3 (3.7) 15.7 (20.9) 0.52 (0.44) 
        
Temperature (C) 32.5 (0.9) 33.7 (1.1) <0.01 32.4 (1.2) 34.1 (1.0) <0.01 (0.17) 
CO2 (kPa) 4.5 (0.5) 4.6 (0.5) 0.09 4.6 (0.4) 4.6 (0.4) 0.72 (0.84) 
BIS  98 (3) 25 (8) <0.01 97 (2) 27 (10) <0.01 (0.42) 
SO2 (%) 99 (1) 99 (1) 0.32 99 (1) 99 (1) 0.41 (0.83) 
MAP (mmHg) 101 (13) 81 (12) <0.01 101 (14) 78 (12) <0.01 (0.55) 
 
 
Values are presented as mean and (SD). P < 0.013 is considered statistically significant. *P-values in 
brackets represent comparison between ‘after PROPOFOL’ and ‘after SEVOFLURANE’.  
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Table 3 : Threshold electrotonus and current/threshold relationship 
 
  
before 
PROPOFOL 
after 
PROPOFOL P value 
before 
SEVOFLURANE 
after 
SEVOFLURANE P value P value* 
TEh(90-100ms) 
% 125.0 (20.8) 119.0 (16.3) 0.28 120.4 (19.7) 122.3 (22.8) 0.68 (0.66) 
TEd(10-20ms) % 58.6 (7.8) 60.6 (5.2) 0.12 61.2 (6.1) 60.4 (8.9) 0.42 (0.89) 
TEd(90-100ms) 
% 42.7 (7.8) 44.6 (7.1) 0.17 44.6 (7.0) 45.6 (10.7) 0.37 (0.72) 
TEh(10-20ms) % 69.6 (12.9) 67.7 (6.9) 0.70 70.9 (9.0) 73.8 (16.2) 0.94 (0.19) 
TEd(undershoot) 
% 21.9 (4.8) 21.9 (4.6) 0.88 21.1 (3.4) 19.0 (3.9) <0.01 (0.03) 
TEh(overshoot) % 20.3 (2.9) 16.1 (3.4) <0.01 19.7 (6.2) 14.5 (5.6) <0.01 (0.36) 
Resting I/V 
slope 0.6 (0.1) 0.6 (0.1) 0.11 0.6 (0.2) 0.6 (0.2) 0.06 (0.50) 
Minimum I/V 
slope 0.3 (0.1) 0.3 (0.1) 0.65 0.3 (0.1) 0.3 (0.1) 0.70 (0.90) 
Hyperpol. I/V 
slope 0.7 (0.5) 2.2 (4.8) 0.84 0.4 (0.1) 0.6 (0.4) 0.29 (0.41) 
 
 
Values are presented as mean and (SD). P < 0.013 is considered statistically significant. *P-values in 
brackets represent comparison between ‘after PROPOFOL’ and ‘after SEVOFLURANE’.  
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Legends to illustrations 
Figure 1. Enrolment and randomisation of patients recruited to the study 
 
Figure 2. Ventilation parameters and temperature during anaesthesia induction. 
A: Endexpiratory CO2 remained stable after the induction of anaesthesia. We therefore can assume 
that tissue pH was unaffected by the anaesthesia induction B: Peripheral oxygen saturation - 
measured with pulsoxymetry on the arm where the recording was made - did not change after the 
induction indicating that no tissue ischemia occurred at the stimulation and recording site. C: The 
temperature at the stimulation site increased significantly during the induction with both general 
anaesthetics. This increase was similar with both, propofol and sevoflurane. D: Mean arterial 
pressure decreased significantly in both groups. The changes occurred in all subjects within a 
physiological range. Solid lines indicate means; dashed lines indicate SEM. Empty circles indicate 
values before induction, grey circles represent propofol, black circles sevoflurane after induction. 
 
Figure 3. Peak response and latency changes. 
A: The stimulus-response curve of the maximum sensory nerve action potential showed a downwards 
shift on the y-axis after induction of anaesthesia with both general anaesthetics. No significant shift 
occurred on the x-axis indicating that the current strength needed to elicit maximum response was not 
affected. B: The size of the maximum peak response was significantly smaller for both anaesthetics 
but no difference was found between the two. The latency of the peak response was not affected in 
either group. Circles indicate the mean current needed to elicit a 50 % of the maximum peak 
response. Empty circles indicate values before induction, grey circles represent propofol, black circles 
sevoflurane after induction. Error bars SEM. 
 
 
Figure 4. Recovery cycle. 
A. The early recovery cycle curve was affected after induction with both anaesthetics. This is best 
illustrated by the shift of the first intersection of the curve with the control threshold (end of the relative 
refractory period). No significant shift on the y-axis at a given interval between the conditioning 
stimulus and test stimulus (interstimulus interval) occurred at interstimulus intervals longer than the 
relative refractory period. This indicates that neither the superexcitable nor the subexcitable periods 
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were affected. B: The maximum extent of the test current changes was equally stable for both, 
superexcitability and subexcitability after induction of anaesthesia with both anaesthetics. The relative 
refractory period was significantly shorter in both groups but not different between the groups. Circles 
represent mean threshold changes at a given interstimulus interval. Empty circles indicate values 
before induction, grey circles represent propofol, black circles sevoflurane after induction. Error bars 
are SEM. 
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Suppl. Methods: Threshold tracking 
 
The threshold-tracking program QTRAC (© Institute of Neurology, Queen Square, London, UK) 
adjusts the stimulus strength in a feed-back controlled manner for different test paradigms to produce 
the target response using proportional tracking.36 In this study we used this technique to investigate 
the excitability parameters of the median nerve by recording antidromically the sensory nerve action 
potential (SNAP) the way it was described for the first time by Kiernan et al. (Suppl. Figure 2A).13 
Throughout the recording protocol, a stimulus frequency of 1 Hz and a stimulus width of 0.5 ms were 
chosen except otherwise stated. 
 
As a first step, a stimulus-response curve was generated. The stimulus strength was gradually 
stepped up until a maximum response of the sensory nerve action potential was reached (Suppl. 
Figure 2B-1). An amplitude of about 40% size of the maximum amplitude was then defined as the 
target amplitude and the stimulus current needed to reach this amplitude was called ‘threshold 
current’. This target amplitude is chosen automatically by the program as the point with the maximal 
slope between 30% and 50% of the stimulus response. The rationale behind the defined ‘threshold 
current’ is that a small change in stimulus strength would have a largest change in amplitude of the 
target response.16 In the following, changes of this ‘threshold current’ were measured continuously in 
response to various test stimulus configurations and automatically adjusted. 
 
Second, to record the strength duration relationship, stimuli of different widths (0.1 ms to 0.5 ms) 
were applied (Suppl. Figure 2B-2). The strength-duration time constant (τSD) was calculated off-line 
from thresholds measured according to Weiss’s formula.37 38 
 
Third, the recovery of excitability following a single supramaximal 0.5-ms conditioning stimulus was 
measured (Suppl. Figure 2B-3). Excitability changes were recorded at 18 different conditioning-test 
intervals decreasing from 200 ms to 1 ms in an approximately geometric sequence. The resulting 
recovery cycle curve allows to identify the different phases of the excitability changes of a nerve after 
a supramaximal stimulus (e.g. relative refractory period, superexcitable period, subexcitable period) 
as described by Raymond (Suppl. Figure 2C).39 Three stimulus conditions were tested in turn (control 
test stimulus, supramaximal conditioning stimulus alone, and the combined conditioning and test 
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stimuli) on three different channels. The response to the conditioning stimulus alone subtracted from 
the response to the combined stimulus results in the effective response to the test stimulus. 
 
Fourth, a threshold electrotonus was recorded (Suppl. Figure 2B-4). The excitability properties of the 
nerve were altered by passing a polarising 100-ms subthreshold current through the whole nerve.  
The polarising currents were set to + 40 % (depolarising) and - 40 % (hyperpolarising) of the 
threshold current. Thresholds were then tested at defined delays between 0 ms and 200 ms during 
and after the start of the polarising current (‘threshold-electrotonus’).40 During this section of the 
protocol, the control, depolarised and hyperpolarised thresholds were tested in turn on three different 
channels of the program.   
 
As a last step the current-voltage relationship was recorded (Suppl. Figure 2B-5). Excitability of the 
nerve was tested at a fix interval of 200 ms after the start of a polarising current.  The polarising 
currents were stepped down from + 50 % (depolarising) of the threshold current to -100 % (= 
hyperpolarising current) in steps of 10 %. During this section of the protocol, the control and the 
thresholds after polarisation were tested in turn on two different channels of the program. 
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Suppl Fig 5: Experimental setup and stimulation protocol.  
A: Setup for excitability measurements: The median nerve was stimulated with the cathode placed at 
the wrist and the anode placed on the radial side of the forearm. A sensory nerve action potential 
(SNAP) was recorded antidromically from Dig. II. The signal was amplified and data were then 
digitized by a data acquisition unit. According to the signal size recorded a ‘threshold tracking’-
software (QTRAC©) adjusted the current applied by the stimulator for each stimulus. If the signal was 
too small as for the defined response size (defined as 40% of the maximum peak response) the 
current of the next stimulus was increased and vice versa. Skin temperature was measured at the 
stimulation site. Oxygen saturation was measured by pulsoxymetry throughout the recording on the 
same side where the recording was being performed. 
B: Graphical depiction of the stimulation patterns used in the protocol. 1: A 0.5 ms rectangular 
stimulus was steadily increased until the size of the SNAP was maximal. 2: To record the strength 
duration relationship, stimuli of different widths (0.1 ms to 0.5 ms) were applied 3: After a 
supramaximal conditioning stimulus, excitability changes were recorded at different conditioning-test 
intervals between 200 ms and 2 ms in an approximately geometrical sequence. 4: To record a 
threshold electrotonus, 100 ms subthreshold polarising currents set to + 40% (depolarising) and - 
40% (hyperpolarising) of the target threshold current were applied. Thresholds were tested at defined 
delays during and after the start of the polarising curr nt. 5: To record the I/V-curve subthreshold 
currents with different polarisation strengths were applied and threshold was tested at 200 ms after 
the start of the polarising current. 
C: The different periods during a recovery cycle of a sensory afferent nerve are illustrated. The 
change of currents of the test stimuli to reach the threshold is plotted on the y-axis in a normalised 
way whereby zero represents the unconditioned control threshold. Immediately after a supramaximal 
conditioning stimulus the nerve enters the refractory period. The refractory period ends as soon as 
the curve crosses the zero line for the first time (indicated with the dashed line). Thereafter, the nerve 
is superexcitable until it becomes subexcitable (second intersection of the curve with the zero line). 
Normal excitability is restored after 200 ms. 
 
Suppl. Fig. 6. Threshold electrotonus. 
A: On the y-axis the reduction of threshold induced by the polarising conditioning current is shown 
(polarising current starts at 10 ms). Positive values imply that a weaker current was needed to reach 
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the threshold and vice versa. Threshold changes were affected by neither of the anaesthetics, 
propofol or sevoflurane, after induction of anaesthesia. B: The histograms of the threshold reduction 
at 100 ms of the conditioning stimulus (indicated by the black arrow in A) illustrate the similarity of the 
measured values before and after the induction of anaesthesia. Circles represent mean threshold 
changes at a given time interval. Empty circles indicate values before induction, grey circles represent 
propofol, black circles sevoflurane after induction. Error bars are SEM. 
 
Suppl. Fig. 7. Current-threshold relationship. 
A: Current-threshold relationship reflects the rectifying properties of the nerve membrane as a 
response to long polarising conditioning currents. On the depolarising side (right from the zero-axis) 
the decrease of excitability reflects outward rectification, on the hyperpolarising side (left from the 
zero-axis) the increase of excitability reflects inward rectification illustrated by the open arrows. B: 
The slope of the current-threshold relationship is the threshold analogue of the conductance. Both, 
minimum slope of the curve on the hyperpolarising side and resting slope (intersection of the two zero 
axis) were not altered by propofol and sevoflurane, respectively. Circles represent mean threshold 
changes at a given polarisation defined as a percentage of the threshold current. Empty circles 
indicate values before induction, grey circles represent propofol, black circles sevoflurane after 
induction. Error bars are SEM. 
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